Possible strategies to prolong circuit life during hemofiltration: Three controlled studies

Renal Failure

Volumn 24, Issue 6, 2002, Pages 839-848

  Baldwin, Ian ^a   Tan, Han Khim ^a   Bridge, Nicholas ^a   Bellomo, Rinaldo ^a  

^a AUSTIN HEALTH   (Australia)

Author keywords

Acute renal failure; Anticoagulation; Clotting; Critical illness; Hemofiltration; Heparin; Polyacrylonitrile; Randomized controlled trial

Indexed keywords

HEPARIN; POLYACRYLONITRILE;

ACUTE KIDNEY FAILURE; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; CROSSOVER PROCEDURE; EXTRACORPOREAL CIRCULATION; HEMOFILTRATION; HOLLOW FIBER MEMBRANE; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBSTITUTION THERAPY; THROMBOCYTE AGGREGATION; TURBULENT FLOW; VASCULAR ACCESS;

ANTICOAGULANTS; BLOOD COAGULATION; COHORT STUDIES; CRITICAL ILLNESS; CROSS-OVER STUDIES; EQUIPMENT FAILURE; HEMOFILTRATION; HEPARIN; HUMANS; KIDNEY FAILURE, ACUTE; TIME FACTORS;

EID: 0036438446     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-120015685     Document Type: Article

References (16)

1. Webb, A.R.; Mythen, M.G.; Jacobsen, D.; Mackie, I.J. Maintaining blood flow in the extracorporeal circuit: Hemostasis and anticoagulation. Intensive Care Med. 1995, 21, 84-93.
2. Baldwin, I.; Elderkin, T. Continuous hemofiltration: Nursing perspective in critical care. New Horiz. 1995, 3(4), 738-747.
3. Ward, D.M.; Mehta, R.L. Extracorporeal management of acute renal failure patients at high risk of bleeding. Kidney Int. 1993, 43(S41), 237-244.
4. Lane, D.A.; Bowry, S.K. The scientific basis for selection of measures of thrombogenecity. Nephrol Dial Transplant 1993, 9(S2), 18-28.
5. Birk, H.W.; Kistner, A.; Wizemann, V.; Schutterle, G. Protein adsorption by artificial membrane materials under filtration conditions. Artif. Organs 1995, 19(5), 411-415.
6. Leslie, G.D.; Jacobs, I.G.; Clarke, G.M. Proximally delivered dilute heparin does not improve circuit life in continuous venovenous hemodiafiltration. Intensive Care Med. 1996, 22, 1261-1264.
7. Bellomo, R. Hemofiltration. In Textbook of Critical Care, 3rd Ed.; Ayres, S.M., Grenvik, A., Holbrook, P.R., Shoemaker, W.C., Eds.; WB Saunders Co: Philadelphia, 1995; Chapter 115, 1041-1053.
8. Davenport, A. The coagulation system in the critically ill patient with acute renal failure and the effect of an extracorporeal circuit. Am. J. Kidney Dis. 1997, 30(5S4), S20-S27.
9. Favre, H.; Martin, P.Y.; Stoermann, C. Anticoagulation in continuous extracorporeal renal replacement therapy. Seminars in Dial. 1996, 9(2), 112-118.
10. Mehta, R.L. Anticoagulation for Continuous Renal Replacement Therapies. In Critical Care Nephrology; Ronco, C., Bellomo, R., Eds.; Section 19, Chapter 5, 1199-1211.
11. Reeves, J.H.; Seal, P.F.; Voss, A.L.; O'Connor, C. Albumin priming does not prolong hemofilter life. ASAIO J. 1997, 43(3), 193-196.
12. Mehta, R.L.; Dobos, G.J.; Ward, D.M. Anticoagulation in continuous renal replacement procedures. Seminars in Dial. 1992, 5, 61-68.
13. Yohay, D.A.; Butterly, D.W.; Schwab, S.J.; Quarles, L.D. Continuous arteriovenous hemodialysis: Effect of dialyzer geometry. Kidney Int. 1992, 42(2), 448-451.
14. Gretz, N.; Quintel, M.; Ragaller, M.; Odenwalder, W.; Bender, H.J.; Rohmeiss, P.; Strauch, M. Low dose-heparinization for anticoagulation in intensive care patients on continuous hemofiltration. Contrib. Nephrol. 1995, 116, 130-135.
15. Bach, L.A.; Sharpe, K. Sample size for clinical and biological research. Aust. NZ. J. Med. 1989, 19, 64-68.
16. Langenecker, S.A.; Felfernig, M.; Werba, A.; Mueller, C.M.; Chiari, A.; Zimpfer, M. Anticoagulation with prostacyclin and heparin during continuous venovenous hemofiltration. Crit. Care. Med. 1994, 22(11), 1774-1781.